University of Patras
Σύγκριση του νεφροσκοπίου 18Fr (πρόσβαση 22Fr) και του νεφροσκοπίου 7,5Fr (πρόσβαση 12Fr) με το συμβατικό νεφροσκόπιο 26Fr (πρόσβαση 30Fr) ως προς τον τραυματισμό του νεφρικού παρεγχύματος κατά τη διαδερμική προσπέλαση του πυελοκαλυκικού συστήματος: κλινική και πειραματική μελέτη
Abstract
dc:descriptionThis study has a clinical and an experimental part. The purpose of the experimental part was to evaluate whether reducing tract dilation diameter in PCNL procedures results in minimizing of renal trauma of the percutaneous tract. To achieve that, a percutaneous renal access tract was established bilaterally to eleven pigs. Two pigs were euthanized immediately after the experiment, while nine pigs were sacrificed one month later. The percutaneous accesses were dilated up to 30Fr, 22Fr or 12Fr. The animals underwent a contrast-enhanced computer tomography immediately after the procedure and 30 days later. DMSA-scintigraphy with SPECT-CT was also performed. The kidneys of all animals were harvested for histological evaluation. The volume of scar tissue and the percentage of renal volume replaced by scar tissue were calculated. Results from the immediate post-procedural CT-scans revealed a significant difference in defect diameter among the three modalities. However, the scar volume calculated on CT-images and histopathology showed a significant difference only when 30Fr dilation was compared to 12Fr dilation. The percentage of scar volume was negligible in all cases, but there was still a statistical difference between 30Fr and 12Fr dilation. Dilation up to 22Fr revealed no statistical differences compared to the other two modalities. DMSA-scintigraphy showed no scar tissue in any case. In conclusion, dilation up to 30Fr may cause a significantly larger scar tissue on renal parenchyma compared to 12Fr dilation as it was shown on CT-images and microscopic evaluation, but based on the DMSA/SPECT-CT this difference seems to be insignificant to the renal function. The scar tissue caused by 22Fr dilation seemed to have no significant difference from the other modalities. The purpose of the clinical part was to compare the safety and efficacy among standard, mini and ultra-mini PCNL (s-PCNL, m-PCNL, um-PCNL). To achieve that, we performed a prospective, non-randomized trial between January 2018 and July 2020. Patients with stones classified as Guy’s stone score grade I were included. The set-up for s-PCNL and m-PCNL included a 30Fr and 22Fr percutaneous tract, respectively. In both set-ups, an ultrasonic/ballistic lithotripter was utilized. In the case of um-PCNL, a 12Fr percutaneous tract was established. A high-power laser was used for lithotripsy. Hemoglobin drop, complication rate, length of hospital stay(LOS), stone-free rate(SFR) and operation time were evaluated. A total of 84 patients, 28 patients per method, were evaluated. Hemoglobin drop was higher in the s-PCNL group when compared to m-PCNL(p=0.008) and um-PCNL groups(p<0.001), while um-PCNL group had the slightest hemoglobin drop. LOS was similar between s-PCNL group and m-PCNL group, but um-PCNL group required shorter hospital stay than the other two modalities(p<0.001). The complication and transfusion rates as well as SFR did not differ between groups. Operation time in the um-PCNL set-up was longer compared to s-PCNL(p<0.001) and m-PCNL(p=0.011), whereas s-PCNL and m-PCNL did not differ significantly. To conclude, m-PCNL showed less hemoglobin drop, but similar operation time and SFR when compared to s-PCNL. um-PCNL showed even less hemoglobin drop, but the operation time was longer compared to the two other modalities.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Adamou, Constantinos
- Αδάμου, Κωνσταντίνος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/55871